<DOC>
	<DOCNO>NCT01427478</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Afatinib maintenance therapy post-operative radiochemotherapy ( 66 Gy Cisplatin dose 100mg/m2 every 3 week ) squamous cell carcinoma head neck .</brief_summary>
	<brief_title>Evaluation Afatinib Maintenance Therapy Squamous Cell Carcinoma Head Neck</brief_title>
	<detailed_description>The reference treatment operate squamous cell carcinoma head neck radiochemotherapy Cisplatin ( dose intravenous 100 mg / m2 IV ) every 3 week ) . The Receptor EGFR ( Epidermal Growth Factor ) REGF membrane receptor ; 's activation lead cellular growth inhibits apoptotic capacity . This receptor overexpressed numerous solid tumor , include ENT tumor . Several clinical study show expression REGF ENT tumor dominant factor poor prognostic . Afatinib ( BIBW2992 ) strong irreversible inhibitor EGFR ( type 1 human epidermic growth factor receptor , also know HER1 ) HER2 ( human epidermal growth factor receptor 2 ) . Currently , 3 phase III clinical study postoperative situation use anti-REGF progress : 2 concomitant situation radiotherapy 1 concomitance adjuvant therapy radiotherapy . The preliminary result phase II study show Afatinib efficient patient local metastatic relapse squamous cell carcinoma sphere ENT first line Cisplatin tolerance correct . These data lead u propose post-operative situation , patient squamous cell carcinoma head neck , radiochemotherapy Cisplatin follow treatment maintenance Afatinib placebo .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>Age ≥ 18 year Histologicallyconfirmed diagnosis non metastatic squamouscell carcinoma oral cavity ; oropharynx , larynx hypopharynx . Macroscopically complete resection disease . Highrisk histological feature define : Microscopically incomplete tumour resection and/or invasion regional lymph node extracapsular extension ( pN+R+ ) Indication radiochemotherapy ( least 60 Gy radiotherapy least 2 cycle chemotherapy ) Start radiochemotherapy within 8 week surgery Performance Status ( PS ) ECOG &lt; = 2 Adequate Blood test , renal liver function 15 day prior inclusion define : Hemoglobin &gt; 9 g/dL Neutrophil count &gt; 1500 x 109/L Platelets &gt; 100 x 109/L Total bilirubin &lt; 1,5x upper limit normal ( ULN ) SGOT SGPT &lt; 2,5 x ULN Alkaline Phosphatase &lt; 2,5 xULN Serum creatinine &lt; 110 µmol/L creatinine clearance &gt; 55 ml/min ( estimate Cockcroft Formula ) Absence proteinuria Women childbearing age must use adequate mean contraception ( oral hormon contraceptive , intrauterine contraceptive device , double barrier method contraception ) . Mandatory affiliation healthy security insurance . Dated sign write informed consent . Macroscopic residual tumour resection ( R2 ) Metastatic disease Prior treatment Head neck cancer chemotherapy , radiotherapy cancer target therapy Prior concomitant malignancy ( except basal cell skin cancer ; situ cervical carcinoma malignancy complete response &gt; 5 year ) History heavy hypersensibility reaction Cisplatin Uncontrolled pulmonary , cardiac , hepatic renal disease . History interstitial pneumopathy Significant cardiovascular disease : Congestive cardiac failure &gt; New York Heart Association ( NYHA ) Class II Myocardial infraction within 6 month prior inclusion Unstable angina Severe cardiac arrythmia Uncontrolled hypertension receive appropriate medication ( ≥ 160 mm Hg systolic and/or ≥ 90 mm Hg diastolic ) Disorder leave ventricular function ejection fraction &lt; 50 % Severe cerebrovascular accident within 6 month prior inclusion History severe thromboembolism within 6 month prior inclusion Cardiovascular baseline QTcB &gt; 480 m ( Calculated Bazett Formula ) Bradycardia Electrolytic disorder Hepatic affection like : hepatitis B C chronic advance decompensated hepatitis hepatitic cirrhosis newly treat chronic hepatitis nowadays treat immunosuppressive drug severe autoimmune hepatitis disease HIV know history Recent digestive symptom diarrhea : Crohn 's disease malabsorption syndrome diarrhea Grade CTC ≥ 2 Active drug alcohol use dependence Pregnant breastfeeding woman , use effective birth control method woman childbearing potential , , men n't accept use effective birth control method study Impossible followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Head neck squamous cell carcinoma</keyword>
	<keyword>Post operative radio-chemotherapy</keyword>
	<keyword>Randomisation</keyword>
	<keyword>Maintenance treatment</keyword>
	<keyword>Afatinib</keyword>
</DOC>